THYROID EYE DISEASE
Clinical trials for THYROID EYE DISEASE explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bulging eyes: drug trial targets thyroid eye disease
Disease control Not yet recruitingThis study tests a new drug called NTB003 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. The trial will include 74 adults aged 18-75 with active disease. Researchers will check if the drug safely reduces eye bulging and other symptoms…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
Second chance for thyroid eye disease patients: new drug trial targets Non-Responders
Disease control Not yet recruitingThis study is for people with thyroid eye disease who did not respond to a previous treatment or whose symptoms returned. It tests a drug called AMG 732 to see if it can reduce eye bulging. About 30 adults will take part, and the main goal is to check for improvement after 24 wee…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
Could fewer infusions tame thyroid eye disease just as well?
Disease control Not yet recruitingThis study compares a shortened 4-infusion course of the drug Teprotumumab (Tepezza) to the standard 8-infusion course in people with active thyroid eye disease (TED). The goal is to see if those who respond well early can safely stop treatment sooner with the same benefits. The …
Matched conditions: THYROID EYE DISEASE
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug aims to reduce bulging eyes in thyroid disease
Disease control Not yet recruitingThis study tests a new drug called teprotumumab N01 against standard steroid treatment for active thyroid eye disease, which causes eye bulging and discomfort. About 92 adults with moderate-to-severe symptoms will be randomly assigned to one of the two treatments. The main goal i…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE4 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC